Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in Proceedings of the American Thoracic Society
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, H. A.
The Proceedings of the American Thoracic Society 2:545-548 (2005)
© 2005 The American Thoracic Society

Inflammation Imaging

Hazel A. Jones

Imperial College London, Hammersmith Campus, London, United Kingdom

Correspondence and requests for reprints should be addressed to Hazel A. Jones, Ph.D., Imperial College London, Hammersmith Campus, London W12 0NN, UK. E-mail: hazel.jones{at}imperial.ac.uk

ABSTRACT

Acute and chronic lung diseases are almost invariably associated with some degree of inflammation. Cells that evolved as an effective mechanism to counter infection and heal lung tissue may, in some circumstances, themselves be partially responsible for the pathogenesis of chronic lung disease that leads to irreversible lung damage and loss of lung function. Although standard measurements of lung function can document the progression of disease, the contributions of the numerous interacting elements to the process are difficult to measure in life. The use of molecular imaging techniques allows the different components of the inflammatory response to be monitored in situ in humans. In particular, positron emission tomography of selected markers targeted to specific cells and biochemical pathways can provide accurate measurements of disease activity, enabling a better understanding of inflammatory processes at all stages of disease. The practicability of sequential measurements allows one to monitor the natural history of different lung diseases. More importantly, imaging provides a unique tool for quantification of the modulation of discrete and specific aspects of inflammatory lung disease by targeted interventions. This should facilitate the development of new treatment strategies with better specificity for key elements of each disease.

Key Words: positron emission tomography • neutrophils • macrophages • extracellular matrix


Related articles in Proceedings of the American Thoracic Society:

COLOR FIGURES (All articles)

Proceedings of the American Thoracic Society 2005 2: 499-516. [Full Text]  



This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
M. B. Dolovich and D. P. Schuster
Positron Emission Tomography and Computed Tomography versus Positron Emission Tomography Computed Tomography: Tools for Imaging the Lung
Proceedings of the ATS, August 1, 2007; 4(4): 328 - 333.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. L. Ehman, W. R. Hendee, M. J. Welch, N. R. Dunnick, L. B. Bresolin, R. L. Arenson, S. Baum, H. Hricak, and J. H. Thrall
Blueprint for Imaging in Biomedical Research
Radiology, July 1, 2007; 244(1): 12 - 27.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. S. Harris and D. P. Schuster
Visualizing lung function with positron emission tomography
J Appl Physiol, January 1, 2007; 102(1): 448 - 458.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Thoracic Society.
 
CCM abstracts